Who owns CULLINAN ONCOLOGY INC?
- Ticker: CGEM
- CUSIP Number: 230031106
Tip: Access positions for across all investors
Analyze quarterly positions in Cullinan Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cullinan Oncology stock
Who bought or sold CULLINAN ONCOLOGY INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Blue Owl Capital Holdings | 3.4M | $35M | 100% | Dec 2023 |
|
Franklin Resources | 3.3M | $33M | 14% | Dec 2023 |
|
BVF | 3.2M | $33M | 0% | Dec 2023 |
|
Vanguard Group | 1.8M | $18M | 5% | Dec 2023 |
|
Braidwell | 1.2M | $13M | -35% | Dec 2023 |
|
American International | 1.2M | $13M | 0% | Dec 2023 |
|
Nextech Invest | 1.2M | $12M | 0% | Dec 2023 |
|
Citadel Advisors | 1.1M | $12M | 7% | Dec 2023 |
|
Dimensional Fund Advisors | 916k | $9.3M | 15% | Dec 2023 |
|
Tang Capital Management | 771k | $7.9M | 24% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 546k | $5.6M | 11717% | Dec 2023 |
|
OrbiMed Advisors | 545k | $5.6M | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 247k | $2.5M | 7% | Dec 2023 |
|
Millennium Management | 233k | $2.4M | -3% | Dec 2023 |
|
Hudson Bay Capital Management | 225k | $2.3M | 0% | Dec 2023 |
|
Kennedy Capital Management | 160k | $1.6M | -67% | Dec 2023 |
|
Schonfeld Strategic Advisors | 141k | $1.4M | 16% | Dec 2023 |
|
UBS Group | 141k | $1.4M | 36% | Dec 2023 |
|
Bank of America Corporation | 135k | $1.4M | 31% | Dec 2023 |
|
Goldman Sachs Group | 128k | $1.3M | 49% | Dec 2023 |
|
DAFNA Capital Management | 127k | $1.3M | 0% | Dec 2023 |
|
Bank of New York Mellon | 99k | $1.0M | 2% | Dec 2023 |
|
Barclays | 85k | $867k | 60% | Dec 2023 |
|
Cubist Systematic Strategies | 57k | $580k | 74% | Dec 2023 |
|
Two Sigma Investments | 50k | $513k | 100% | Dec 2023 |
|
D. E. Shaw & Co | 49k | $499k | 23% | Dec 2023 |
|
Swiss National Bank | 46k | $472k | 20% | Dec 2023 |
|
Rhumbline Advisers | 46k | $466k | 1% | Dec 2023 |
|
Alliancebernstein | 43k | $442k | -1% | Dec 2023 |
|
Credit Suisse | 43k | $437k | 120% | Dec 2023 |
|
Martingale Asset Management | 43k | $433k | 0% | Dec 2023 |
|
Algert Coldiron Investors | 41k | $418k | 148% | Dec 2023 |
|
Two Sigma Advisers | 39k | $393k | 100% | Dec 2023 |
|
Trexquant Investment | 35k | $356k | 100% | Dec 2023 |
|
New York Life Investment Management | 34k | $344k | -3% | Dec 2023 |
|
Marshall Wace | 33k | $340k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 25k | $257k | 4% | Dec 2023 |
|
T. Rowe Price Associates | 22k | $225k | 53% | Dec 2023 |
|
Hsbc Holdings | 22k | $221k | 0% | Dec 2023 |
|
Commonwealth Equity Services | 21k | $214k | 0% | Dec 2023 |
|
Squarepoint Ops | 20k | $205k | 100% | Dec 2023 |
|
CornerCap Investment Counsel | 19k | $191k | 1% | Dec 2023 |
|
Quest Partners | 18k | $179k | 100% | Dec 2023 |
|
Exchange Traded Concepts | 17k | $287k | 20% | Mar 2024 |
|
Harbor Capital Advisors | 15k | $147k | 41% | Dec 2023 |
|
SG Americas Securities | 14k | $147k | 12% | Dec 2023 |
|
Mirae Asset Global Investments | 14k | $144k | 0% | Dec 2023 |
|
Legal & General Group | 14k | $143k | 0% | Dec 2023 |
|
Jane Street | 14k | $141k | -17% | Dec 2023 |
|
MetLife Investment Advisors | 13k | $136k | 0% | Dec 2023 |
|
Annandale Capital | 12k | $122k | 0% | Dec 2023 |
|
Virtus ETF Advisers | 11k | $111k | 29% | Dec 2023 |
|
Bailard | 11k | $110k | 100% | Dec 2023 |
|
Principal Financial Group | 11k | $109k | -2% | Dec 2023 |
|
Citigroup | 11k | $108k | -55% | Dec 2023 |
|
GSA Capital Partners | 10k | $104k | 100% | Dec 2023 |
|
Vontobel Holding | 10k | $102k | 100% | Dec 2023 |
|
Royal Bank of Canada | 8.9k | $92k | -9% | Dec 2023 |
|
Wells Fargo & Company | 8.0k | $82k | 35% | Dec 2023 |
|
New York State Common Retirement Fund | 6.7k | $68k | -1% | Dec 2023 |
|
Zurcher Kantonalbank | 6.5k | $67k | 0% | Dec 2023 |
|
China Universal Asset Management | 5.0k | $50k | 352% | Dec 2023 |
|
Point72 Asia | 2.9k | $29k | 100% | Dec 2023 |
|
Russell Investments | 2.3k | $23k | 100% | Dec 2023 |
|
Summit Investment Advisors | 2.0k | $20k | 0% | Dec 2023 |
|
Parallel Advisors | 1.3k | $13k | 100% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.3k | $13k | 0% | Dec 2023 |
|
Point72 Middle East FZE | 1.2k | $12k | -83% | Dec 2023 |
|
Amalgamated Bank | 896.00 | $15k | -59% | Mar 2024 |
|
Signature | 858.00 | $8.7k | 42% | Dec 2023 |
|
Simplex Trading | 511.00 | $5.0k | -51% | Dec 2023 |
|
Us Bancorp | 504.00 | $5.1k | 100% | Dec 2023 |
|
GAMMA Investing | 496.00 | $8.5k | 20% | Mar 2024 |
|
Lindbrook Capital | 291.00 | $3.0k | 100% | Dec 2023 |
|
Quadrant Capital | 241.00 | $2.5k | 100% | Dec 2023 |
|
Washington Trust Advisors | 127.00 | $1.3k | 0% | Dec 2023 |
|
Daiwa Securities Group | 127.00 | $999.998000 | 0% | Dec 2023 |
|
NISA Investment Advisors | 117.00 | $1.2k | -17% | Dec 2023 |
|
Massmutual Trust | 36.00 | $613.000800 | 0% | Mar 2024 |
|
CWM | 33.00 | $999.999000 | 14% | Mar 2024 |
|
Pnc Financial Services | 17.00 | $173.000500 | 6% | Dec 2023 |
|
Who sold out of Cullinan Oncology?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Boxer Capital | Sep 2023 | 1.1M | $9.7M |
AQR Capital Management | Sep 2023 | 22k | $197k |
Federated Investors | Sep 2023 | 20k | $181k |
State of Wisconsin Investment Board | Sep 2023 | 15k | $138k |
Point72 Asset Management | Sep 2023 | 224.00 | $2.0k |
Covestor | Sep 2023 | 123.00 | $1.0k |
Baker Avenue Asset Management | Sep 2023 | 48.00 | $434.001600 |